CD274 and neoplasm: With the use of immune checkpoint inhibitors (ICIs), PD-1 inhibitors (PD-1/PD-L1 inhibitors), blocks the interaction between PD-L1 and PD-1, removes the inhibitory effect on T-cells, and controls tumor growth (14).